Session Details

This session will address cardiotoxicities of novel breast cancer therapies, strategies for risk assessment and cardioprotection, and innovative clinical trial approaches to improve cardiac outcomes.

Moderator

Alexandra Thomas, Duke University, Durham, NC

Presentation numberED13-01

Cardiotoxicity of breast cancer novel therapies

Anne H Blaes, University of Minnesota, Minneapolis, MN

Presentation numberED13-02

Approaches for cardioprotection in cancer care

Eric H Yang, UCLA, Los Angeles, CA

Presentation numberED13-03

Trial strategies to optimize cardiac outcomes

Javid Moslehi, University of California San Francisco, San Francisco, CA

Advocate

Aj Veach, Savvy Cooperative, Washington D.C., MD